ARCHIVES

DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year

This article is from The Cancer Letter archive.

Vol. 07 No. 28 | July 10, 1981

Download PDF Visit The Full Archive

Related Articles

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program

April 17, 1981

Pittsburgh Reprimands Staff For Use of Univ. Resources In Mailing

May 13, 1994

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

In Brief: David Cole Named President of The Medical University of South Carolina

May 9, 2014